Tubo-ovarian abscess. Prevalence in four decades at Hospital Nacional Arzobispo Loayza
DOI:
https://doi.org/10.31403/rpgo.v58i84Abstract
Background: Tubo-ovarian abscess (TOA) is the response of female genitalia to focus infection; the abscess capsule allows perpetuation of the infection by isolation of germs and reduces antibiotics performance, becoming necessary surgical intervention as part of the problem solution. TOA is sequel of septic abortion, pelvic inflammatory disease (PID), and less frequently due to puerperal infection. Abscess rupture can be mortal. Objectives: To determine variation of tubo-ovarian abscess prevalence at a Peruvian national hospital since 1970 through 2010. Design: Retrospective study. Setting: Hospital Arzobispo Loayza, Lima, Peru. Participants: Women with tubo-ovarian abscess. Interventions: Review of clinical charts of patients with tubo-ovarian abscess and determination of the cause and variation throughout time. Main outcome measures: Prevalence and causes of tuboovarian abscess during four decades. Results: TOA decreased over the time studied with inversion of its main cause; in the early stage of this study the major cause was septic abortion (SA), whereas in recent years PID became the major cause. Conclusions: During the four decades studied tubo-ovarian abscess frequency decreased and the main cause septic abortion was displace by pelvic inflammatory disease.Downloads
References
Joiner KA, Onderdonk AB, Gelfand JA, Bartlett JG, Gorbach SL. A quantitative model for subcutaneous abscess formation in mice. Brit J Exp Pathol. 1980;61(1):97-107.
Jacoby GA, Archer GL. New mechanisms of bacterial resistance to antimicrobial agents. N.Engl Med. 1991;324(9):601-12.
Kunin CM. Problems in antibiotic usage. En: Mandell GL, Douglas RG, Bennett JE (eds): Principles and practice of infectious diseases. Ed 3. New York: Churchill Livingstone, 1990:427.
Lanier LL, Phillips JH. Evidence for three types of human cytotoxic lymphocyte. Trends Inmunol. 1986;7(5):132-4.
Red KBM. The complement system. En: Hames BD, Glover DM (eds).: Molecular Inmunology. Oxford, England: IRL Press, 1989:189.
Barlett JG, Sullivan-Sigler N, Louie TJ, Gorbach SL. Anaerobes survive in clinical specimens despite delayed processing. J Clin Microbiol. 1976:3(2):133-6.
Mc Murray LM, Park BH, Burdett V, Levy SB. Energy dependent efflux mediated by class L (tet L) tetracycline resistant determinant from streptococci. Antimicrob Agents Chemother. 1987;31(10):1648-50.
Rusthoven JJ, Davies TA, Lerner SA. Clinical isolation and characterization of aminoglycoside-resistant small colony variants of Enterobacter aerogenes. Am J Med. 1979;67(4):702-6.
Brian LE, van den Elzen HM. Streptomycin accumulation in susceptible and resistant strains of Escherichia coli and Pseudomonas auruginosa. Antimicrob Agents Chemother. 1976;19(6):928-38.
Mandell GL. Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infec Inmun. 1974;9(2):337-41.
Ingham HR, Selkon JB, Codd AA, Hale JH. The effect of carbón dioxide on the sensitivity of Bacteroides fragilis to certain antibiotics in vitro. J Clin Pathol. 1970;23(3):254-8.
Siu A. El plastrón anexial en la enfermedad pélvica inflamatoria. Tesis Doctoral. UPCH 1995. Lima-Perú
Walker CK, Landers DV. Pelvic abscesses: new trends in management. Obstet Gynecol Surv. 1991;46:615-24.
Pastorek JG. Pelvic inflammation disease and tubo-ovarian abscess. Obstet Gynecol Clin NA. 1989;16(2):34-61.
Siu A. Conceptos, diagnósticos y tratamiento del plastón anexial y absceso tubo-ovárico no roto. Diagnóstico. 1990;25(5-6):81-5.
Camus E, Nisand I. Consecuencias médicas del aborto provocado en la salud de la mujer. Rev Prat. 1995;45:2361-9.
Fischer M, Bhatnagar J, Guarner J, Reagan S, Hacker JK, et al. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med. 2005;353(22):2352-60.
Norman JE, Thong KJ. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet. 1997;338:1233-6.
Koopersmith TB, Mishell DR. The use of misoprostol for termination for early pregnancy. Contraception. 1996;53:237-42.
Bugalno A, Bique C, Machungo F, Faundes A. Induction of labor with intravaginal mysoprostol in intrauterine fetal death. Am J Obstet Gynecol. 1994;171:538.
Coll A. Embarazo en la adolescencia. Clínicas Perinatológicas Argentinas, Nº 4, 1997.
Rodríguez Armas O, Santiso Gálvez R, Calventi V. Maternidad adolescente. Ginecología, Fertilidad y Salud Reproductiva, FLASOG, 1996, Vol. 1, Cap. 32.
Távara L. Contribución de las adolescentes a la muerte materna en el Perú, Rev. Per Ginecol Obstet. 2004;50 (2):111–22.
De la Cruz G, Bautista M. Estudio clínico-epidemiológico de la enfermedad pélvica inflamatoria aguda. Hospital Nacional Arzobispo Loayza. Rev Per Ginecol Obstet. 2005;51:126-31.
Gray-Swain MR, Peipert JF. Pelvic inflammatory disease in adolescents. Current Opinion in Obstetrics & Gynecology. 2006;18(5):503-10.
BASHH. Clinical Effectiveness Group British Association for Sexual Health and HIV. UK National Guideline for the management of Pelvic Inflammatory Disease 201. BASHH PID guideline 2011.
Judlin P. Current concepts in managing pelvic inflammatory disease. Curr Opin Infect Dis. 2010;23(1):83-7
Downloads
Published
How to Cite
Issue
Section
License
Esta revista provee acceso libre inmediato a su contenido bajo el principio de que hacer disponible gratuitamente la investigación al publico, lo cual fomenta un mayor intercambio de conocimiento global.
